TAM
Tocqueville Asset Management’s Acurx Pharmaceuticals ACXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500
| Closed | -$19K | – | 536 |
|
|
2024
Q3 | $19K | Hold |
500
| – | – | ﹤0.01% | 524 |
|
|
2024
Q2 | $22.5K | Hold |
500
| – | – | ﹤0.01% | 524 |
|
|
2024
Q1 | $24.5K | Sell |
500
-155
| -24% | -$7.6K | ﹤0.01% | 533 |
|
|
2023
Q4 | $50.2K | Buy |
655
+150
| +30% | +$11.5K | ﹤0.01% | 511 |
|
|
2023
Q3 | $15.2K | Hold |
505
| – | – | ﹤0.01% | 510 |
|
|
2023
Q2 | $26.8K | Hold |
505
| – | – | ﹤0.01% | 532 |
|
|
2023
Q1 | $34.9K | Hold |
505
| – | – | ﹤0.01% | 525 |
|
|
2022
Q4 | $40.2K | Hold |
505
| – | – | ﹤0.01% | 570 |
|
|
2022
Q3 | $30K | Hold |
505
| – | – | ﹤0.01% | 591 |
|
|
2022
Q2 | $38K | Hold |
505
| – | – | ﹤0.01% | 657 |
|
|
2022
Q1 | $33K | Sell |
505
-750
| -60% | -$49K | ﹤0.01% | 702 |
|
|
2021
Q4 | $108K | Buy |
1,255
+300
| +31% | +$25.8K | ﹤0.01% | 726 |
|
|
2021
Q3 | $98K | Buy |
955
+455
| +91% | +$46.7K | ﹤0.01% | 719 |
|
|
2021
Q2 | $64K | Buy |
+500
| New | +$64K | ﹤0.01% | 732 |
|